Literature DB >> 7341755

A liner mode of reversible metabolism and its application to bioavailability assessment.

S Hwang, K C Kwan, K S Albert.   

Abstract

A theoretical basis has been established for the bioavailability assessment of drug and metabolite wherein the biotransformation of one to the other is reversible. The method is applicable to linear systems and requires knowledge of drug metabolite clearance rates as well as the rate of their interconversion. While not necessary, an unconventional definition of plasma clearance appears desirable and expeditious. Depending on the experimental situation, clearance values may change between treatments; these changes should be recognized and accommodated. Alterations in experimental design are discussed as means to minimize the need for assumptions and/or to provide data in suitable form as tests of internal consistency.

Mesh:

Substances:

Year:  1981        PMID: 7341755     DOI: 10.1007/bf01070901

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  10 in total

1.  Comparative disposition of sulindac and metabolites in five species.

Authors:  D E Duggan; K F Hooke; R M Noll; H B Hucker; C G Van Arman
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

2.  Pharmacokinetics in man of the N-acetylated metabolite of procainamide.

Authors:  J M Strong; J S Dutcher; W K Lee; A J Atkinson
Journal:  J Pharmacokinet Biopharm       Date:  1975-08

3.  Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man.

Authors:  K C Kwan; G O Breault; E R Umbenhauer; F G McMahon; D E Duggan
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

4.  Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.

Authors:  W A Colburn; C R Sibley; R H Buller
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

5.  N-acetylprocainamide: an active metabolite of procainamide.

Authors:  D E Drayer; M M Reidenberg; R W Sevy
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

6.  Novel method for bioavailability assessment.

Authors:  K C Kwan; A E Till
Journal:  J Pharm Sci       Date:  1973-09       Impact factor: 3.534

7.  The polymorphic acetylation of dapsone in man.

Authors:  R Gelber; J H Peters; G R Gordon; A J Glazko; L Levy
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

8.  Metabolism of procainamide in rhesus monkey and man.

Authors:  J Dreyfuss; J T Bigger; A I Cohen; E C Schreiber
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

9.  Oral activated charcoal and dapsone elimination.

Authors:  P J Neuvonen; E Elonen; M J Mattila
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

10.  Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.

Authors:  D E Duggan; K F Hooke; S S Hwang
Journal:  Drug Metab Dispos       Date:  1980 Jul-Aug       Impact factor: 3.922

  10 in total
  10 in total

1.  The pharmacokinetics of trilostane and ketotrilostane in an interconverting system in the rat.

Authors:  J P McGee; P N Shaw
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

2.  Mean interconversion times and distribution rate parameters for drugs undergoing reversible metabolism.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

3.  Primary, secondary, and tertiary metabolite kinetics.

Authors:  M V St-Pierre; X Xu; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

Review 4.  Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.

Authors:  H Cheng; W J Jusko
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

Review 5.  Clinical pharmacokinetics of D-penicillamine.

Authors:  P Netter; B Bannwarth; P Péré; A Nicolas
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

6.  Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.

Authors:  G M Pollack; K L Brouwer
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

7.  Interconversion between haloperidol and reduced haloperidol in healthy volunteers.

Authors:  B S Chakraborty; J W Hubbard; E M Hawes; G McKay; J K Cooper; T Gurnsey; E D Korchinski; K K Midha
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits.

Authors:  W F Ebling; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1986-12

9.  Pharmacokinetics and reversible biotransformation of sulfinpyrazone and its metabolites in rabbits. I. Single-dose study.

Authors:  W A Ritschel
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

Review 10.  Understanding the pharmacokinetics of reversible metabolism.

Authors:  Seungil Cho; Young-Ran Yoon
Journal:  Transl Clin Pharmacol       Date:  2019-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.